We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » White House Still Waiting on Industry’s Alternative Drug Pricing Plan as Deadline Hits
White House Still Waiting on Industry’s Alternative Drug Pricing Plan as Deadline Hits
As of Friday evening, the pharma industry had still not put forward a price-cutting strategy that could sway the president into discarding a drug pricing executive order he has threatened to enforce.